Beta Bionics (BBNX) Other Operating Expenses (2024 - 2026)

Beta Bionics has disclosed Other Operating Expenses across 3 years of filings, most recently posting $10.2 million for Q2 2026.

• In Q2 2026, Other Operating Expenses rose 15.41% year-over-year to $10.2 million; the TTM figure through Jun 2026 stood at $38.9 million (up 26.3% YoY), while the FY2025 annual figure was $34.8 million, up 32.86% from the prior year.
• Other Operating Expenses came in at $10.2 million for Q2 2026 at Beta Bionics, down from $10.4 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $10.4 million in Q1 2026 to a low of $5.1 million in Q3 2024.
• Average Other Operating Expenses over 3 years is $8.2 million, with a median of $8.5 million recorded in 2025.
• The largest YoY upside for Other Operating Expenses was 59.4% in 2025 against a maximum downside of 9.95% in 2025.
• Over 3 years, Other Operating Expenses stood at $9.2 million in 2024, then increased by 9.95% to $10.1 million in 2025, then climbed by 1.08% to $10.2 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $10.2 million in Q2 2026, $10.4 million in Q1 2026, and $10.1 million in Q4 2025.